Comment
. 2008 Dec;7(12):1081-2; author reply 1083-5.
doi: 10.1016/S1474-4422(08)70248-5.
Guillain-Barré syndrome
- PMID: 19007731
- DOI: 10.1016/S1474-4422(08)70248-5
Item in Clipboard
Comment
Guillain-Barré syndrome
Lancet Neurol.
2008 Dec.
No abstract available
Comment on
-
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.Lancet Neurol. 2008 Oct;7(10):939-50. doi: 10.1016/S1474-4422(08)70215-1. Lancet Neurol. 2008. PMID: 18848313 Review.
Similar articles
-
Treatment of Guillain-Barré syndrome.J Infus Nurs. 2013 Nov-Dec;36(6):397-400. doi: 10.1097/NAN.0000000000000011. J Infus Nurs. 2013. PMID: 24202119 Review.
-
Treatment for Guillain-Barré syndrome.Ann Neurol. 2009 Nov;66(5):569-70. doi: 10.1002/ana.21816. Ann Neurol. 2009. PMID: 19938064 No abstract available.
-
[Acute and chronic inflammatory neuropathies--therapy].Dtsch Med Wochenschr. 2003 Jun 20;128(25-26):1405-7. doi: 10.1055/s-2003-40104. Dtsch Med Wochenschr. 2003. PMID: 12813675 Review. German. No abstract available.
-
[Treatment of Guillain-Barré Syndrome].Brain Nerve. 2015 Nov;67(11):1397-410. doi: 10.11477/mf.1416200312. Brain Nerve. 2015. PMID: 26560955 Review. Japanese.
-
A retrospective survey of the quality of reports and their correlates among randomized controlled trials of immunotherapy for Guillain-Barré syndrome.Immunotherapy. 2013 Aug;5(8):829-36. doi: 10.2217/imt.13.75. Immunotherapy. 2013. PMID: 23902552
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
